PV 2024

Call for Papers

This conference will serve as a knowledge-sharing and networking platform, providing a unique opportunity for researchers, pharmacists, healthcare professionals, industry representatives, and regulatory authorities to come together and discuss the latest trends, challenges, and advancements in pharmacovigilance. By sharing experiences and best practices, we aim to enhance global drug safety and improve patient outcomes. Throughout the conference, we will delve into various topics such as signal detection and management, adverse event reporting and analysis, risk assessment, benefit-risk evaluation, regulatory updates, collaboration and the integration of artificial intelligence and digital technologies in pharmacovigilance.

 Our esteemed panel of speakers, comprising leading experts from academia, industry, and regulatory agencies, will present their research findings, share case studies, and engage in thought-provoking discussions. The conference will also feature interactive networking opportunities, fostering collaboration and enabling the exchange of ideas.

 We are delighted to welcome you to the Pharmacovigilance World 2024, and we are confident that your active participation will contribute to the advancement of drug safety practices. Together, let us strive towards a safer and more vigilant healthcare system that prioritizes patient well-being and ensures the continued benefit of medications worldwide.

Key Highlights:

• Pharmacovigilance and globalization

• Pharmacovigilance in a pandemic world

• Women and child health care medicines and pharmacovigilance

• Patient-centric approaches in PV

• Pharmacovigilance legislation and regulations

• Harmonization and pharmacovigilance

• Advanced therapeutic techniques and pharmacovigilance

• Pharmacovigilance and data management and eudravigilance

• Post-marketing surveillance in pharmacovigilance

• PV regulations and challenges

• Benefit-risk management strategies

• Risk management and minimization

• Risk Evaluation and Mitigation

• Adverse drug reactions reporting

• Signal detection and post authorization safety

• Good Pharmacovigilance Practices

• Innovative approaches to drug safety

• Strategies to improve PV

• Real World Evidence in PV

• Big data and AI in pharmacovigilance

• Pharmacovigilance Workflows with AI & Automation

• Other emerging technologies in PV

Who should attend the conference?

Attendees include GMs, VPs, Directors, Heads and Managers of:

• Pharmacovigilance

• Safety & Risk management

• Drug safety

• PV Compliance

• Safety Surveillance

• Medical Affairs

• Regulatory Affairs

• Inspection and Audit

• Pharmacoepidemiology

• Post-market studies

• Medical product safety assessment

• Drug Research & Development

• Clinical Pharmacology

• Medical information

• Contract outsourcing service providers

• Health outcomes

• Sales and Marketing